Acute Ischemic Stroke
6 competing products in clinical development for Acute Ischemic Stroke.
Pipeline by Phase
Pre-clinical1
Phase 11
Phase 1/21
Phase 23
All Products (6)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Redasemtide + Placebo | Shionogi | Phase 2 | Active | 39 |
| YM872 (zonampanel), t-PA (alteplase) | Astellas Pharma | Phase 2 | Completed | 35 |
| DS-1040b + Placebo | Daiichi Sankyo | Phase 1/2 | Completed | 32 |
| XY03-EA + XY03-EA Placebo | Sun Pharmaceutical | Phase 2 | UNKNOWN | 31 |
| DS-1040b + Aspirin | Daiichi Sankyo | Phase 1 | Completed | 29 |
| DS1040b + Placebo | Daiichi Sankyo | Pre-clinical | Completed | 26 |